American International Group, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

American International Group, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.39 - $2.21 $62,224 - $98,932	-44,766 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$1.27 - $3.42 $149 - $403	118 Added 0.26%	44,766 $88,000
Q4 2020 Feb 12, 2021	SELL	$0.94 - $1.89 $10 - $20	-11 Reduced 0.02%	44,648 $56,000
Q3 2020 Nov 04, 2020	BUY	$1.5 - $9.38 $6,208 - $38,823	4,139 Added 10.21%	44,659 $80,000
Q2 2020 Aug 12, 2020	BUY	$4.79 - $8.39 $7,405 - $12,970	1,546 Added 3.97%	40,520 $340,000
Q1 2020 May 04, 2020	BUY	$3.44 - $7.21 $6,202 - $12,999	1,803 Added 4.85%	38,974 $204,000
Q4 2019 Feb 05, 2020	SELL	$4.29 - $5.64 $1,334 - $1,754	-311 Reduced 0.83%	37,171 $203,000
Q3 2019 Nov 08, 2019	SELL	$4.87 - $7.08 $1,275 - $1,854	-262 Reduced 0.69%	37,482 $183,000
Q2 2019 Aug 13, 2019	BUY	$6.6 - $7.8 $18,975 - $22,425	2,875 Added 8.25%	37,744 $262,000
Q1 2019 May 06, 2019	BUY	$5.76 - $8.95 $11,681 - $18,150	2,028 Added 6.18%	34,869 $242,000
Q4 2018 Feb 13, 2019	SELL	$5.26 - $7.97 $1,325 - $2,008	-252 Reduced 0.76%	32,841 $192,000
Q3 2018 Nov 09, 2018	BUY	$4.65 - $7.95 $2,771 - $4,738	596 Added 1.83%	33,093 $250,000
Q2 2018 Aug 08, 2018	BUY	$5.05 - $6.8 $5,560 - $7,486	1,101 Added 3.51%	32,497 $164,000
Q1 2018 May 07, 2018	SELL	$5.6 - $9.25 $7,022 - $11,599	-1,254 Reduced 3.84%	31,396 $192,000
Q4 2017 Feb 09, 2018	BUY	$6.6 - $7.78 $19,509 - $22,997	2,956 Added 9.95%	32,650 $232,000
Q3 2017 Nov 09, 2017	BUY	$5.75 - $7.75 $170,740 - $230,128	29,694	29,694 $212,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.